These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34274283)

  • 1. Pulmonary Artery
    Maier A; Liao SL; Lescure T; Robson PM; Hirata N; Sartori S; Narula N; Vergani V; Soultanidis G; Morgenthau A; Kovacic JC; Padilla M; Narula J; Jacobi A; Fayad ZA; Trivieri MG
    JACC Cardiovasc Imaging; 2022 Jan; 15(1):108-120. PubMed ID: 34274283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thoracic [18F]fluorodeoxyglucose uptake measured by positron emission tomography/computed tomography in pulmonary hypertension.
    Frille A; Steinhoff KG; Hesse S; Grachtrup S; Wald A; Wirtz H; Sabri O; Seyfarth HJ
    Medicine (Baltimore); 2016 Jun; 95(25):e3976. PubMed ID: 27336898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
    Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
    JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
    J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of
    Xi XY; Gao W; Gong JN; Guo XJ; Wu JY; Yang YH; Yang MF
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1395-1403. PubMed ID: 30747369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio of (18)F-FDG activity uptake between the right and left ventricle in patients with pulmonary hypertension correlates with the right ventricular function.
    Yang T; Wang L; Xiong CM; He JG; Zhang Y; Gu Q; Zhao ZH; Ni XH; Fang W; Liu ZH
    Clin Nucl Med; 2014 May; 39(5):426-30. PubMed ID: 24662662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis.
    Trivieri MG; Robson PM; Vergani V; LaRocca G; Romero-Daza AM; Abgral R; Devesa A; Azoulay LD; Karakatsanis NA; Parikh A; Panagiota C; Palmisano A; DePalo L; Chang HL; Rothstein JH; Fayad RA; Miller MA; Fuster V; Narula J; Dweck MR; Morgenthau A; Jacobi A; Padilla M; Kovacic JC; Fayad ZA
    JACC Cardiovasc Imaging; 2024 Apr; 17(4):411-424. PubMed ID: 38300202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.
    Ahmed AI; Abebe AT; Han Y; Alnabelsi T; Agrawal T; Kassi M; Aljizeeri A; Taylor A; Tleyjeh IM; Al-Mallah MH
    J Nucl Cardiol; 2021 Aug; 28(4):1545-1552. PubMed ID: 34228337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of serial quantitative evaluation of
    Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Dimensional Echocardiography for the Assessment of Right Ventriculo-Arterial Coupling.
    Aubert R; Venner C; Huttin O; Haine D; Filippetti L; Guillaumot A; Mandry D; Marie PY; Juilliere Y; Chabot F; Chaouat A; Selton-Suty C
    J Am Soc Echocardiogr; 2018 Aug; 31(8):905-915. PubMed ID: 29958760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of fluorodeoxyglucose positron emission tomography in malignancy of pulmonary artery mimicking pulmonary embolism.
    Lee EJ; Moon SH; Choi JY; Lee KS; Choi YS; Choe YS; Lee KH; Kim BT
    ANZ J Surg; 2013 May; 83(5):342-7. PubMed ID: 22943630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
    Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
    Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
    Adhaduk M; Paudel B; Khalid MU; Ashwath M; Mansour S; Liu K
    J Nucl Cardiol; 2023 Aug; 30(4):1574-1587. PubMed ID: 36443587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of fusion
    Okune M; Yasuda M; Soejima N; Kagioka Y; Kakehi K; Kawamura T; Hanaoka K; Kaida H; Ishii K; Nakazawa G; Miyazaki S; Iwanaga Y
    J Nucl Cardiol; 2022 Apr; 29(2):753-764. PubMed ID: 33000410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of pulmonary artery activity in patients with Takayasu's arteritis.
    Gao W; Gong JN; Guo XJ; Wu JY; Xi XY; Ma ZH; Yang YH; Yang MF
    Eur Heart J Cardiovasc Imaging; 2021 Apr; 22(5):541-550. PubMed ID: 32793972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance.
    Sanz J; Kariisa M; Dellegrottaglie S; Prat-González S; Garcia MJ; Fuster V; Rajagopalan S
    JACC Cardiovasc Imaging; 2009 Mar; 2(3):286-95. PubMed ID: 19356573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.